Manipal Health Enterprises IPO: GMP Hints At Modest Listing, Check Price Band, Lot Size, and Other Details

The subscription window for the initial public offering (IPO) of Manipal Health Enterprises will open on July 29 and close on July 31. The company has fixed the price band for the public issue at Rs 560 to Rs 590 per share. Here is a look at some of the key details related to the public issue:

Manipal Health Enterprises IPO Issue Size

Manipal Health Enterprises seeks to raise Rs 9,275.22 crore from its public issue. The issue comprises a fresh issue of 135.6 million shares aggregating to Rs 8,000 crore and an offer for sale (OFS) of 21.6 million shares aggregating to Rs 1,275.22 crore.

Manipal Health Enterprises IPO Price Band and Lot Size

The price band for Manipal Health Enterprises IPO has been fixed between Rs 560 and Rs 590 per share. Retail individual investors will be able to bid for the issue by applying for a minimum of 25 shares, which aggregates to an investment of Rs 14,750 at the upper end of the price band.

Manipal Health Enterprises IPO GMP

The grey market premium (GMP) for Manipal Health Enterprises shares is currently ranging between Rs 25 and Rs 35 per share. Based on the upper end of the price band at Rs 590, the estimated listing price is expected to be in the range of Rs 615 to Rs 625. This is expected to lead to a positive but modest listing gain of around 4.24 per cent to 5.93 per cent for the stock.

Manipal Health Enterprises IPO: Subscription Dates and Listing Date

The subscription window opens on July 29 and will close on July 31. The basis of allotment for the IPO is expected to be finalised on August 3. Refunds for unsuccessful applicants will be initiated on August 4, and shares will be credited to demat accounts on the same day. The company's shares are tentatively scheduled to list on the BSE and NSE on August 5.

Manipal Health Enterprises: Financials

In the financial year ended March 31, 2026, Manipal Health Enterprises posted a total income of Rs 10,520.52 crore, an increase of nearly 26 per cent from Rs 8,362.79 crore in the preceding fiscal year ending March 31, 2025. However, the company's profit after tax (PAT) saw a decrease of 15.26 per cent, standing at Rs 916.52 crore for the fiscal year ended March 31, 2026, compared to Rs 1,081.67 crore in the previous fiscal.

Manipal Health Enterprises IPO: Registrar

The registrar for the Manipal Health Enterprises IPO is Kfin Technologies. The book-running lead managers for the issue include Kotak Mahindra Capital, Axis Capital, Goldman Sachs (India) Securities Pvt, Jefferies India, JP Morgan India, UBS Securities India Pvt and DBS Bank India.

Manipal Health Enterprises: Promoters

The promoters of the company include Ranjan Ramdas Pai, Manipal Global Health Services, Memg International Ltd., Kangto Investments Pte. Ltd., Imperius Healthcare Investments Pte. Ltd., and Kabru Investments Pte. Pre-issue, the promoters hold an 81.43 per cent stake in the company, which is expected to reduce to 72.08 per cent post-issue.

About Manipal Health Enterprises

Manipal Health Enterprises is a healthcare service provider that operates a network of multi-speciality hospitals, clinics, and diagnostic centres across India. The company is a part of the Manipal Group, founded by T. M. A. Pai. The company offers healthcare services including tertiary and quaternary care, organ transplants, oncology, cardiology, neurology, orthopaedics, and preventive healthcare.